Cargando…
Corrigendum to “Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A” [Contraception 2016;93:498–506]
Autores principales: | Rowe, Patrick, Farley, Tim, Peregoudov, Alexandre, Piaggio, Gilda, Boccard, Simone, Landoulsi, Sihem, Meirik, Olav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357721/ https://www.ncbi.nlm.nih.gov/pubmed/27312266 http://dx.doi.org/10.1016/j.contraception.2016.06.001 |
Ejemplares similares
-
Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A()()
por: Rowe, Patrick, et al.
Publicado: (2016) -
Impact of immediate postpartum insertion of TCu380A on the quantity and duration of lochia discharges in Tanzania
por: Muganyizi, Projestine Selestine, et al.
Publicado: (2021) -
A one-year cohort study of complications, continuation, and failure rates of postpartum TCu380A in Tanzania
por: Rwegoshora, France John, et al.
Publicado: (2020) -
Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling
por: Ali, Moazzam, et al.
Publicado: (2017) -
Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant
por: Ali, Moazzam, et al.
Publicado: (2016)